Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017
- TransCon Growth Hormone Data Support Ongoing Phase 3 heiGHt Trial - - Late-Breaking Posters on TransCon PTH and TransCon... Read More
Ascendis Pharma A/S Announces Updated Time for April 3 Conference Call to Review ENDO 2017 Data
COPENHAGEN, Denmark, March 31, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that util... Read More